General information about company

Scrip code523144
NSE Symbol
MSEI Symbol
ISININE442D01010
Name of the entityMEDI-CAPS LMITED
Date of start of financial year01-04-2020
Date of end of financial year31-03-2021
Reporting QuarterYearly
Date of Report31-03-2021
Risk management committeeNot Applicable
Market Capitalisation as per immediate previous Financial YearAny other



Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatoryTextual Information(1)
Wether the listed entity has a Regular ChairpersonYes
Whether Chairperson is related to MD or CEOYes
SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directors Date of BirthWhether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations]Date of passing special resolutionInitial Date of appointmentDate of Re-appointmentDate of cessationTenure of director (in months)No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations)No of Independent Directorship in listed entities including this listed entity (Refer Regulation 17A(1) of Listing RegulationsNumber of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)Notes for not providing PANNotes for not providing DIN
1MrRAMESH CHANDRA MITTALABZPM1785C00035272Non-Executive - Non Independent DirectorChairperson16-06-1947NA06-08-198326-07-20161000
2MrALOK K GARGAAHPG5352J00274321Executive DirectorNot ApplicableMD27-04-1969NA01-04-200701-04-20191010
3MrsKUSUM MITTALABZPM1784D00035356Non-Executive - Non Independent DirectorNot Applicable08-08-1950NA04-05-199116-10-20191000
4MrASHOK OMPRAKASH AGRAWALABTPA2337G07870578Non-Executive - Independent DirectorNot Applicable16-07-1960NA25-07-2017451133



I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatory

Wether the listed entity has a Regular Chairperson

SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directors Date of BirthWhether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations]Date of passing special resolutionInitial Date of appointmentDate of Re-appointmentDate of cessationTenure of director (in months)No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations)No of Independent Directorship in listed entities including this listed entity (Refer Regulation 17A(1) of Listing RegulationsNumber of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)Notes for not providing PANNotes for not providing DIN
5MrPRAMOD FATEHPURIAAAAPF7695N00972389Non-Executive - Independent DirectorNot Applicable20-08-1961NA29-05-201429-05-2019831130
6MrDHARMENDRA SOLANKIBAWPS4119K09055239Non-Executive - Independent DirectorNot Applicable24-09-1975NA05-02-202121120



Text Block

Textual Information(1)
Mr. Pramod Fatehpuria was initially appointed as Independent Director of the Company for first term of five years w.e.f. 29.05.2014. Please note that members have already given their consent in their annual general meeting held on 25.09.2018 for his re-appointment as independent director for a second term of five years w.e.f. 29.05.2019.
 
Mr. Dhamendra Solanki was appointed as an additional non-executive independent director of the Company in the meeting held on 05th Feburary, 2021, subject to approval of members in the ensuing Annual General Meeting.
 
During the quarter, the Audit committee, Stakholders relationship committee and Nomination and remuneration committee were reconstituted w.e.f. 5th February, 2021 due to ceassation of  committee member  by Mrs. Kusum Mittal and appointment of Mr. Dhamendra Solanki as the member of all Committees.



Annexure 1

II. Composition of Committees

Disclosure of notes on composition of committees explanatoryTextual Information(1)

Annexure 1 Text Block

Textual Information(1)
During the quarter, the Audit committee, Stakholders relationship committee and Nomination and remuneration committee were reconstituted w.e.f. 5th February, 2021 due to ceassation of  committee member  by Mrs. Kusum Mittal and appointment of Mr. Dhamendra Solanki as the member of all Committees.


Audit Committee Details

Whether the Audit Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
107870578ASHOK OMPRAKASH AGRAWALNon-Executive - Independent DirectorChairperson20-02-2020
200972389PRAMOD FATEHPURIANon-Executive - Independent DirectorMember30-05-2017
300035356KUSUM MITTALNon-Executive - Non Independent DirectorMember23-11-202005-02-2021Textual Information(1)
409055239DHARMENDRA SOLANKINon-Executive - Independent DirectorMember05-02-2021Textual Information(2)

Sr Text Block

Textual Information(1)
Mrs. Kusum Mittal membership of the Audit Committe ceased w.e.f. 05.02.2021.
Textual Information(2)
Mr. Dharmendra Solanki was appointed as an member of Audit Committee w.e.f. 05.02.2021.


Nomination and remuneration committee

Whether the Nomination and remuneration committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
107870578ASHOK OMPRAKASH AGRAWALNon-Executive - Independent DirectorChairperson20-02-2020
200972389PRAMOD FATEHPURIANon-Executive - Independent DirectorMember30-05-2017
300035356KUSUM MITTALNon-Executive - Non Independent DirectorMember23-11-202005-02-2021Textual Information(1)
409055239DHARMENDRA SOLANKINon-Executive - Independent DirectorMember05-02-2021Textual Information(2)

Sr Text Block

Textual Information(1)
Mrs. Kusum Mittal membership of the Nomination & Remuneration committee ceased w.e.f. 05.02.2021.
Textual Information(2)
Mr. Dharmendra Solanki was appointed as an member of Nomination & Remuneration  Committee w.e.f. 05.02.2021.


Stakeholders Relationship Committee

Whether the Stakeholders Relationship Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
107870578ASHOK OMPRAKASH AGRAWALNon-Executive - Independent DirectorChairperson16-10-2019
200972389PRAMOD FATEHPURIANon-Executive - Independent DirectorMember20-02-2020
300035356KUSUM MITTALNon-Executive - Non Independent DirectorMember23-11-202005-02-2021Textual Information(1)
409055239DHARMENDRA SOLANKINon-Executive - Independent DirectorMember05-02-2021Textual Information(2)

Sr Text Block

Textual Information(1)
Mrs. Kusum Mittal membership of Stakeholders Relationship committee ceased w.e.f. 05.02.2021.
Textual Information(2)
Mr. Dharmendra Solanki was appointed as an member of Stakeholders Relationship Committee w.e.f. 05.02.2021.


Risk Management Committee

Whether the Risk Management Committee has a Regular Chairperson
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks


Corporate Social Responsibility Committee

Whether the Corporate Social Responsibility Committee has a Regular Chairperson
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks


Other Committee

SrDIN NumberName of Committee membersName of other committeeCategory 1 of directorsCategory 2 of directorsRemarks
107870578ASHOK OMPRAKASH AGRAWALINDEPENDENT DIRECTORS COMMITTEENon-Executive - Independent DirectorChairperson
200972389PRAMOD FATEHPURIAINDEPENDENT DIRECTORS COMMITTEENon-Executive - Independent DirectorMember
309055239DHARMENDRA SOLANKIINDEPENDENT DIRECTORS COMMITTEENon-Executive - Independent DirectorMemberTextual Information(1)

Other Committee Text Block

Textual Information(1)
Mr. Dharmendra Solanki was appointed as an member of Independent Directors Committee w.e.f. 05.02.2021.



Annexure 1

Annexure 1

III. Meeting of Board of Directors

Disclosure of notes on meeting of board of directors explanatory
SrDate(s) of meeting (if any) in the previous quarterDate(s) of meeting (if any) in the current quarterMaximum gap between any two consecutive (in number of days)Notes for not providing DateWhether requirement of Quorum met (Yes/No)Number of Directors present*No. of Independent Directors attending the meeting*
106-11-2020Yes31
205-02-202190Yes31



Annexure 1

IV. Meeting of Committees

Disclosure of notes on meeting of committees explanatory
SrName of CommitteeDate(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order)Maximum gap between any two consecutive (in number of days)Name of other committeeReson for not providing dateWhether requirement of Quorum met (Yes/No)Number of Directors present*No. of Independent Directors attending the meeting*
1Audit Committee06-11-2020Yes22
2Audit Committee05-02-202190Yes32
3Nomination and remuneration committee05-02-2021Yes32
4Stakeholders Relationship Committee05-02-2021Yes32



Annexure 1

V. Related Party Transactions

SrSubjectCompliance status (Yes/No/NA)If status is �No� details of non-compliance may be given here.
1Whether prior approval of audit committee obtainedYes
2Whether shareholder approval obtained for material RPTNA
3Whether details of RPT entered into pursuant to omnibus approval have been reviewed by Audit CommitteeYes
Disclosure of notes on related party transactions Textual Information(1)


Text Block

Textual Information(1)
No material related party transactions were entered during the year. Further transactions that were entered are in ordinary course of business and at arms lenth basis. 
 



Annexure 1

VI. Affirmations

SrSubjectCompliance status (Yes/No)
1The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015Yes
2The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit CommitteeYes
3The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committeeYes
4The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committeeYes
5The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 500 listed entities)NA
6The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
7The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
8This report and/or the report submitted in the previous quarter has been placed before Board of Directors.Yes

Annexure 1

SrSubjectCompliance status
1Name of signatoryAyushi Silot
2DesignationCompany Secretary and Compliance Officer



Text Block




Annexure II

Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)

I. Disclosure on website in terms of Listing Regulations

SrItemCompliance status (Yes/No/NA)If status is �No� details of non-compliance may be given here.Web address
1Details of businessYeshttp://medicaps.com/wp-content/uploads/2019/10/Amendments-to-MoA.pdf
2Terms and conditions of appointment of independent directorsYeshttp://medicaps.com/?page_id=7282
3Composition of various committees of board of directorsYeshttp://medicaps.com/?page_id=6437
4Code of conduct of board of directors and senior management personnelYeshttp://medicaps.com/?page_id=7280
5Details of establishment of vigil mechanism/ Whistle Blower policyYeshttp://medicaps.com/?page_id=7280
6Criteria of making payments to non-executive directorsYeshttp://medicaps.com/wp-content/uploads/2016/06/Remuneration-Policy.pdf
7Policy on dealing with related party transactionsYeshttp://medicaps.com/wp-content/uploads/2016/06/Related-party-transaction-Policy.pdf
8Policy for determining �material� subsidiariesYeshttp://medicaps.com/wp-content/uploads/2016/06/Policy-for-determining-Material-Subsidiary.pdf
9Details of familiarization programmes imparted to independent directorsYeshttp://medicaps.com/wp-content/uploads/2016/06/Familarization-Programe-of-IDs.pdf

Annexure II

Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)

I. Disclosure on website in terms of Listing Regulations

SrItemCompliance status (Yes/No/NA)If status is �No� details of non-compliance may be given here.Web address
10Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievancesYeshttp://medicaps.com/?page_id=7724
11email address for grievance redressal and other relevant detailsYeshttp://medicaps.com/?page_id=7724
12Financial resultsYeshttp://medicaps.com/?page_id=7347
13Shareholding patternYeshttp://medicaps.com/?page_id=7267
14Details of agreements entered into with the media companies and/or their associatesNA
15Schedule of analyst or institutional investor meet and presentations made by the listed entity to analysts or institutional investors simultaneously with submission to stock exchangeNA
16New name and the old name of the listed entityNA
17Advertisements as per regulation 47 (1)Yeshttp://medicaps.com/?page_id=6791
18Credit rating or revision in credit rating obtainedNA
19Separate audited financial statements of each subsidiary of the listed entity in respect of a relevant financial yearYeshttp://medicaps.com/?page_id=7256
20Whether company has provided information under separate section on its website as per Regulation 46(2)Yeshttp://medicaps.com/?page_id=7280
21Materiality Policy as per Regulation 30Yeshttp://medicaps.com/?page_id=7280
22Dividend Distribution policy as per Regulation 43A (as applicable)NA
23It is certified that these contents on the website of the listed entity are correctYeswww.medicaps.com


Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is �No� details of non-compliance may be given here.
1Independent director(s) have been appointed in terms of specified criteria of �independence� and/or �eligibility�16(1)(b) & 25(6)Yes
2Board composition17(1), 17(1A) & 17(1B)Yes
3Meeting of Board of directors17(2)Yes
4Quorum of Board meeting17(2A)Yes
5Review of Compliance Reports17(3)Yes
6Plans for orderly succession for appointments17(4)Yes
7Code of Conduct17(5)Yes
8Fees/compensation17(6)Yes
9Minimum Information17(7)Yes
10Compliance Certificate17(8)Yes

Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is �No� details of non-compliance may be given here.
11Risk Assessment & Management17(9)Yes
12Performance Evaluation of Independent Directors17(10)Yes
13Recommendation of Board17(11)Yes
14Maximum number of Directorships17AYes
15Composition of Audit Committee18(1)Yes
16Meeting of Audit Committee18(2)Yes
17Composition of nomination & remuneration committee19(1) & (2)Yes
18Quorum of Nomination and Remuneration Committee meeting19(2A)Yes
19Meeting of Nomination and Remuneration Committee19(3A)Yes
20Composition of Stakeholder Relationship Committee20(1), 20(2) & 20(2A)Yes

Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is �No� details of non-compliance may be given here.
21Meeting of Stakeholders Relationship Committee20(3A)Yes
22Composition and role of risk management committee21(1),(2),(3),(4)NA
23Meeting of Risk Management Committee21(3A)NA
24Vigil Mechanism22Yes
25Policy for related party Transaction23(1),(1A),(5),(6),(7) & (8)Yes
26Prior or Omnibus approval of Audit Committee for all related party transactions23(2), (3)Yes
27Approval for material related party transactions23(4)NA
28Disclosure of related party transactions on consolidated basis23(9)Yes
29Composition of Board of Directors of unlisted material Subsidiary24(1)Yes
30Other Corporate Governance requirements with respect to subsidiary of listed entity24(2),(3),(4),(5) & (6)Yes

Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is �No� details of non-compliance may be given here.
31Annual Secretarial Compliance Report24(A)Yes
32Alternate Director to Independent Director25(1)Yes
33Maximum Tenure25(2)Yes
34Meeting of independent directors25(3) & (4)Yes
35Familiarization of independent directors25(7)Yes
36Declaration from Independent Director25(8) & (9)Yes
37D & O Insurance for Independent Directors25(10)NA
38Memberships in Committees26(1)Yes
39Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel26(3)Yes
40Disclosure of Shareholding by Non-Executive Directors26(4)Yes
41Policy with respect to Obligations of directors and senior management26(2) & 26(5)Yes
Any other information to be provided - Add Notes




Annexure II

1Name of signatoryAyushi Silot
2DesignationCompany Secretary and Compliance Officer



Annexure II

III. Affirmations

SrParticularsCompliance status (Yes/No/NA)
1The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been compliedYes
Any other information to be provided




Annexure II

1Name of signatoryAyushi Silot
2DesignationCompany Secretary and Compliance Officer



Signatory Details

Name of signatoryAyushi Silot
Designation of personCompany Secretary and Compliance Officer
PlaceIndore
Date13-04-2021